Dispensaries Archives

AgraFlora Organics International (AGRA.C) gets the Home Office nod for entry into the U.K. medical cannabis market

January 23, 2020

AgraFlora Organics International’s (AGRA.C) European subsidiary Farmako GmbH has received the go-ahead from the Home Office in the U.K. for a controlled drug licence.

Vext Science (VEXT.C) cannabis chart defies gravity

Lukas Kane

January 14, 2020

“The core business, which is derived from an Arizona licensed vertically integrated model, generated USD $13 million in revenues during the first two quarters of 2019,” confirmed Equity Guru’s Sam Bourgi last October. Ironically, VEXT is a healthy cannabis business, and investors are quickly gaining confidence in it.

This is an actual MedMen (MMEN.C) news release

Chris Parry

January 10, 2020

When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing to higher interest rates and offer stock to new financiers at a discount to the market price, all to stay afloat, one might expect their newsflow to show bold new moves, innovation, maybe some hard austerity decisions.

1933 Industries (TGIF.C) forges ahead in California despite slumping cannabis market

Joseph Morton

January 7, 2020

1933 Industries (TGIF.C) announced that they’re ready to begin manufacturing their line of CBD wellness products, and debuted their subsidiary, Alternative Medicine Association’s, branded THC products for the first time for the California dispensary market.

SLANG Worldwide (SLNG.C) enters a new US market

Lukas Kane

January 6, 2020

This deal gives Standard Wellness an exclusive license to produce and distribute the SLANG product suite in Ohio. SLANG will derive revenue for each branded product sold in the state, with sales expected to begin in 2020.

AgraFlora Organics (AGRA.C) makes their European Union debut with the Good Company and Farmako

Joseph Morton

January 3, 2020

AgraFlora Organics International (AGRA.C) closed its deal to acquire the Good Company GmbH, the parent of the German EU medical cannabis distributor, Farmako GmbH.

2019 weed wrap: The end of the cannabis cycle of cannabis cycles

Chris Parry

December 27, 2019

Like the old Twilight Zone episode where helpful aliens leave behind a book called 'To Serve Man', only for us to find out later it's a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they're at the predator's table because they're the main course.

High Tide’s (HITI.C) brand tries to get its freak on with 20th century counterculture icon, but younger crowds left cold

Joseph Morton

December 27, 2019

Famous Brandz, one of High Tide’s (HITI.C) subsidiaries, signed into a royalty-based merchandising license with FFFB Media LLC to use The Fabulous Furry Freak Brothers trademarks, names, logos and artwork.

Agraflora Organics (AGRA.C) takes full advantage of a changing environment

Joseph Morton

December 20, 2019

Agraflora Organics International (AGRA.C) is opening farm-gate stores in a high population density area with hopes of attracting new customers, while taking greater control of their in-house production.

Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it

Chris Parry

December 12, 2019

If you've been around this joint for a while, you'll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do. That's not because we have a hate on for the dude-bros running the show, or because they're not a client, or because we're short sellers, or any of the other 50 or so reasons MedMen homers have thrown at us over the last few years as a rationale for us not seeing the company in the same rose-coloured way they do. It's because MedMen is, and has always been, shit.

CLS Holdings (CLSH.C) completes phase 1 of Las Vegas cannabis facility

Lukas Kane

December 5, 2019

On December 5, 2019 CLS Holdings (CLSH.C) announced that it has completed the buildout and licensing for phase 1 of its north Las Vegas processing facility.